EICHOR

Recruiting studies: Neoplasms Rectal

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Se
Phase 1 · 3 location(s) · Molecure S.A. · NCT05759923 The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Phase 1/Phase 2 · 77 location(s) · PMV Pharmaceuticals, Inc · NCT04585750 Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer
Phase N/A · 1 location(s) · Helse Stavanger HF · NCT01762813 A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 an
Phase 2 · 39 location(s) · Ono Pharmaceutical Co., Ltd. · NCT06948448 Telehealth Intervention for Ostomy Self-Management
Phase 2 · 1 location(s) · City of Hope Medical Center · NCT06528990 Personalized Health Self-Management Training for Colorectal Cancer Survivors
NA · 2 location(s) · University of Southern California · NCT05984589 Perioperative Outcomes After Neoadjuvant Therapy in Colorectal Cancer
Phase N/A · 1 location(s) · Osijek University Hospital · NCT07422974 KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer
Phase 1/Phase 2 · 1 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT07353645 CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
EARLY_Phase 1 · 1 location(s) · Zhejiang University · NCT06937567 Single cEll pRofiling PErsistaNce To ImmuNothErapy
Phase 2 · 1 location(s) · Vall d'Hebron Institute of Oncology · NCT06680739 Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases
Phase 3 · 1 location(s) · Fudan University · NCT04687631 Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac
NA · 1 location(s) · University Hospital Tuebingen · NCT04172753 Clinicopathological Characteristics of Colon Cancer in Young Age
Phase N/A · 1 location(s) · Seoul National University Bundang Hospital · NCT05365412 Predicting Colorectal Cancer - Tissue Samples to Evaluate Tumour Characteristics and Treatment Response
Phase N/A · 1 location(s) · Sahlgrenska University Hospital · NCT04130971 mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC
Phase 3 · 1 location(s) · Jun Huang · NCT06791512 Hyperthermia With Chemoradiotherapy in Rectal Cancer
NA · 2 location(s) · University Hospital Tuebingen · NCT06831981 A Study on the Accurate Evaluation of Pseudoprogression of Rectal Cancer Immunotherapy Based on Multitemporal and Multip
Phase N/A · 2 location(s) · Peiyi Xie · NCT07381322 Randomized Trial Comparing Fecal Testing (FIT) to Colonoscopy for Post-polypectomy Surveillance
NA · 1 location(s) · Sorlandet Hospital HF · NCT06983639 LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Phase N/A · 225 location(s) · University of Rochester · NCT06073431 Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Colorectal Cancer：M
Phase N/A · 1 location(s) · Shanghai Minimally Invasive Surgery Center · NCT07068529 ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC
Phase 2 · 1 location(s) · Beijing Hospital · NCT06321081 cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Phase N/A · 17 location(s) · Adela, Inc · NCT05366881 Metabolomics to Predict Treatment Response and Toxicities in Rectal Cancer
Phase N/A · 1 location(s) · Chang Gung Memorial Hospital · NCT06831669 Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With TAS-102 (Lonsurf) and Bevacizumab in Re
NA · 1 location(s) · Charite University, Berlin, Germany · NCT05991102 Genomic Investigation of Unusual Responders
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT03740503 A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer
Phase 1/Phase 2 · 22 location(s) · GlaxoSmithKline · NCT07213609 A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Phase 1/Phase 2 · 26 location(s) · Frontier Medicines Corporation · NCT06244771 Early Ileostomy Closure for Rectal Cancer Patients in North America
NA · 4 location(s) · Jewish General Hospital · NCT05027737 Hypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R)
Phase 2 · 1 location(s) · Fudan University · NCT07183865 A First-In-Human Trial of pTTL in Advanced Colorectal Cancer
Phase 1/Phase 2 · 2 location(s) · Neogap Therapeutics AB · NCT05908643

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →